SomaLogic Inc., a Boulder-based bioscience firm, along with partners at the University of Chicago, University of California Los Angeles, University of California Santa Barbara and University of Washington, were recently awarded a $1 million grant from the National Science Foundation to develop devices that use quantum sensing methods for proteomic screening.

Proteomic screening is the process of detecting proteins in biological samples such as blood or urine.

“If successful, the new…

… Continue Reading at: [source]